Treatment of Post-Streptococcal Glomerulonephritis with Cephalosporins
Cephalosporins are appropriate alternatives to penicillin for treating post-streptococcal glomerulonephritis when penicillin allergy exists or when beta-lactamase producing organisms are suspected, with first-generation cephalosporins (e.g., cephalexin) preferred for uncomplicated cases and third-generation cephalosporins (e.g., ceftriaxone) reserved for severe infections or resistant organisms. 1, 2
Antibiotic Selection Algorithm
First-Line Therapy
- Penicillin remains the gold standard for PSGN treatment, even when active infection has resolved, as the goal is to reduce streptococcal antigenic load rather than treat active infection 1, 2
- Erythromycin is the alternative for patients with penicillin allergy 1
When to Use Cephalosporins
First-generation cephalosporins (cephalexin) are appropriate for:
Third-generation cephalosporins (ceftriaxone) should be used for:
Dosing Recommendations
While specific dosing for PSGN is not explicitly detailed in the guidelines, standard streptococcal infection dosing applies:
- Cephalexin: Standard dosing for streptococcal infections (typically 250-500 mg orally every 6 hours in adults; 25-50 mg/kg/day divided every 6-8 hours in children) 3
- Ceftriaxone: 1-2 g IV/IM every 24 hours in adults; 50-75 mg/kg/day in children for severe infections 4
Critical Management Principles
Antibiotic Therapy Rationale
- Administer antibiotics regardless of whether active infection is still present—the primary goal is reducing antigenic load, not treating active infection 1, 2
- This is a common pitfall: clinicians may withhold antibiotics when throat culture is negative or skin lesions have healed, but treatment is still indicated 1
- During outbreaks, systemic antimicrobials help eliminate nephritogenic strains of Streptococcus pyogenes from the community 1
Supportive Care Takes Priority
The cornerstone of PSGN management is supportive care, not antibiotics alone:
Fluid and Blood Pressure Management:
- Restrict dietary sodium to <2.0 g/day 1, 2
- Use loop diuretics as first-line agents for fluid overload and hypertension 1, 2
- Target blood pressure <130/80 mmHg (or <125/75 mmHg if proteinuria >1 g/day) 2
- Monitor closely for diuretic complications: hyponatremia, hypokalemia, GFR reduction, and volume depletion 1, 2
Additional Supportive Measures:
- Treat metabolic acidosis if serum bicarbonate <22 mmol/L 1, 2
- Provide dialysis for severe acute kidney injury with uremia, refractory fluid overload, or life-threatening hyperkalemia 1
Immunosuppression: Rarely Indicated
- Reserve corticosteroids ONLY for severe crescentic PSGN with rapidly progressive glomerulonephritis 1, 2
- Do NOT use immunosuppression for typical PSGN—the disease is self-limited with excellent prognosis 1
- Evidence for corticosteroids is anecdotal at best 1, 2
Monitoring Parameters
Complement Levels
- C3 complement should normalize within 8-12 weeks in uncomplicated cases 1, 2
- If C3 remains low beyond 12 weeks, perform kidney biopsy to exclude complement C3 glomerulonephritis (C3GN) 1, 2
Ongoing Assessment
- Monitor serum creatinine, eGFR, blood pressure, urinalysis with microscopy, and urine protein-to-creatinine ratio regularly 1
- Assess for complications including pulmonary edema, congestive heart failure, and hypertensive encephalopathy 5
Special Considerations
Alternative Antibiotics
- Amoxicillin/clavulanate (co-amoxiclav) provides excellent coverage against streptococcal organisms and achieves adequate tissue concentrations 1
- This combination is particularly useful when beta-lactamase producing organisms are suspected 1
When Biopsy is Indicated
Kidney biopsy should be performed when:
- Diagnosis remains uncertain or presentation is atypical 1, 2
- C3 remains persistently low beyond 12 weeks 1, 2
- Rapidly progressive glomerulonephritis with crescentic features is suspected 1, 2